- Home
- Bicalutamide Key patent SPC and data exclusivity expiry 7 country coverage
Bicalutamide Key patent SPC and data exclusivity expiry 7 country coverage
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013
- $ 2 000
- Company report
- by Global Markets Direct
- May 2013
- 48 pages
Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development ...
Industries: Drug and Medication | Countries: World, India, Australia
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Acuvax Ltd (ACU)
- $ 250
- Company report
- by Global Data
- May 2013
- 26 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Acuvax Ltd (ACU) SWOT Analysis report provides you a strategic analysis ...
Industries: Drug and Medication | Countries: Australia, United States
Vaccine Market in Australia
- $ 652
- Industry report
- by Global Research & Data Services
- May 2013
- 19 pages
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Australia. The study provides essential market information for decision-makers including: - Overall market for vaccines in Australia - Market for vaccines by type - Forecasts and ...
Industries: Drug and Medication | Countries: Australia
Edmond Pharma Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- by Global Data
- May 2013
- 19 pages
Summary Edmond Pharma Srl (Edmond Pharma) is a pharmaceutical company. The company produces active ingredients, finished products, and pharmaceutical specialties for generic market. It operates through two divisions such as chemical plant and pharmaceutical plant. The company's active ingredients include ...
Industries: Drug and Medication | Countries: Australia
Australia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012
- $ 1 088
- Industry report
- by Business Monitor International
- May 2013
- 117 pages
Includes 3 FREE quarterly updates BMI View: Given the country's increasingly ageing population and the consequential rise in noncommunicable diseases, Australia is a highly attractive place for multinational industry players despite lower growth potential compared to emerging industries. However, we ...
Industries: Drug and Medication | Countries: Australia
BioDiem Ltd - Product Pipeline Review - 2013
- $ 1 500
- Company report
- by Global Markets Direct
- April 2013
- 46 pages
BioDiem Ltd - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?BioDiem Ltd - Product Pipeline Review - 2013? provides data on the BioDiem Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest ...
Industries: Drug and Medication | Countries: India, Australia, United States, World
Pathology in United States: Diphtheria - Pipeline Review, H1 2012
- $ 2 000
- Company report
- by Global Markets Direct
- April 2013
- 69 pages
This report provides data on the therapeutic development for Diphtheria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diphtheria. 'Diphtheria - Pipeline Review, H1 2012' is built using ...
Industries: Drug and Medication | Countries: Japan, World, United States, Australia
STADA Arzneimittel AG (Symbol:SAZ) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- April 2013
- 36 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. STADA Arzneimittel AG SWOT Analysis report provides you a strategic ...
Industries: Drug and Medication | Countries: Germany, Belgium, Australia
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
- $ 3 500
- Industry report
- by GBI Research
- April 2013
- 137 pages
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants Summary GBI Research, the leading business intelligence provider has released its latest research ...
Industries: Drug and Medication | Countries: Philippines, Singapore, New Zealand, Australia, Malaysia, Taiwan, Japan, China, Asia, India, Oceania, World
Novogen Limited (Symbol:NRT) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- March 2013
- 33 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Novogen Limited SWOT Analysis report provides you a strategic analysis ...
Industries: Drug and Medication | Countries: Australia
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- (866) 682 9815
ref:plp2013
Reportlinker.com © Copyright 2013. All rights reserved.
